News

Novartis has completed its entire shipment of seasonal influenza vaccine to the US for the 2009/2010 season. As anticipated, the company delivered 27 million doses of Fluvirin influenza

The Japan Patent Office has granted Avita Medical a Japanese patent entitled: Improved drug delivery device and methods therefore. The intellectual property covered under the patent follows patents

MD Biosciences (MDB) has launched MD Bioproducts. The new division allows MD Biosciences to expand it’s product offering for immunology and cell biology research. The company said that

R-Tech Ueno has initiated early phase II clinical trial for RK-023, a physiologically active fatty acid derivative developed by the company – a new compound targeted as a

Gen-Probe has signed an agreement to acquire Prodesse for approximately $60m in cash. Gen-Probe’s purchase price could increase to up to $85m if Prodesse achieves certain financial and

Enzon Pharmaceuticals has announced that the European Commission has approved its Cimzia for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia (certolizumab

The European Commission has approved Simponi (alone or in combination with methotrexate) as a once-monthly, subcutaneous therapy for the treatment of moderate-to-severe, active rheumatoid arthritis, active and progressive

TOPICA Pharmaceuticals has announced results from its phase 2 clinical study evaluating luliconazole, in patients with tinea pedis (athlete’s foot). The study was designed to assess the effectiveness

Huebner has over 35 years of experience in the diagnostic industry, and has been worked for number of clinical diagnostic companies including Hybritech, Inc., Gen-Probe, Inc., Nanogen, Inc.